99 related articles for article (PubMed ID: 1975317)
1. Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract.
Pyrhönen S; Valtonen M
Lancet; 1990 Jul; 336(8707):127. PubMed ID: 1975317
[No Abstract] [Full Text] [Related]
2. Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer.
Porta C; Nastasi G; Spaghi A; Moroni M
Lancet; 1990 Dec; 336(8728):1454-5. PubMed ID: 1978920
[No Abstract] [Full Text] [Related]
3. Comparison of 5-fluorouracil, doxorubicin and mitomycin C with 5-fluorouracil alone in the treatment of pancreatic-biliary carcinomas.
Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T
Oncology; 1994; 51(5):396-400. PubMed ID: 8052479
[TBL] [Abstract][Full Text] [Related]
4. 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
Abad A; Rosell R; Barnadas A; Carles J; Ribelles N; Solano V
Ann Oncol; 1991 Feb; 2(2):153. PubMed ID: 2054318
[No Abstract] [Full Text] [Related]
5. Chemotherapy for pancreatic carcinoma.
Kao GD
Lancet; 1991 Jan; 337(8734):177. PubMed ID: 1670814
[No Abstract] [Full Text] [Related]
6. Sequential high-dose methotrexate, 5-fluorouracil, and doxorubicin for treatment of advanced pancreatic cancer.
Scheithauer W; Funovics J; Mueller C; Ludwig H
J Cancer Res Clin Oncol; 1990; 116(2):132-3. PubMed ID: 2324155
[TBL] [Abstract][Full Text] [Related]
7. [Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
Takada T; Kato H; Sasaki M; Matsushiro T; Yamauchi H; Kajihara T; Watanabe G; Hanaue H; Yoshida K; Shimizu T
Gan To Kagaku Ryoho; 1992 Aug; 19(9):1295-301. PubMed ID: 1503483
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy in cancers of the gallbladder and bile ducts].
Okada S; Okazaki N
Gan To Kagaku Ryoho; 1991 Jul; 18(8):1269-72. PubMed ID: 2069397
[TBL] [Abstract][Full Text] [Related]
9. An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreas.
Wils J; Bleiberg H; Dalesio O; Duez N; Blijham G; Planting A; Splinter T; Weber W
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):1017-8. PubMed ID: 3478197
[TBL] [Abstract][Full Text] [Related]
10. Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.
Pino MS; Milella M; Gelibter A; Sperduti I; De Marco S; Nuzzo C; Bria E; Carpanese L; Ruggeri EM; Carlini P; Cognetti F
Oncology; 2009; 76(4):254-61. PubMed ID: 19246950
[TBL] [Abstract][Full Text] [Related]
11. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
[TBL] [Abstract][Full Text] [Related]
12. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of advanced pancreatic cancer with 5-fluorouracil, doxorubicin and high-dose methotrexate].
Scheithauer W; Ludwig H; Zielinski C; Funovics J; Knoflach P; Müller C; Grabner G
Leber Magen Darm; 1988 Jun; 18(3):149-55. PubMed ID: 3043129
[TBL] [Abstract][Full Text] [Related]
14. Etoposide, doxorubicin and cisplatin alternating with 5-fluorouracil, doxorubicin and high-dose methotrexate in patients with advanced adenocarcinoma of the stomach or the gastroesophageal junction.
Bar Sela G; Tsalic M; Gaitini D; Steiner M; Haim N
J Chemother; 2002 Dec; 14(6):623-6. PubMed ID: 12583555
[TBL] [Abstract][Full Text] [Related]
15. Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study.
Cantore M; Fiorentini G; Mambrini A; Rabbi C; Zamagni D; Carlone N; Manni A; Caudana R; Torri T
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):59-64. PubMed ID: 16767908
[TBL] [Abstract][Full Text] [Related]
16. Outcome of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in patients with refractory advanced biliary tract cancer.
Lim KH; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Oncology; 2012; 83(2):57-66. PubMed ID: 22760079
[TBL] [Abstract][Full Text] [Related]
17. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer.
Glimelius B; Hoffman K; Sjödén PO; Jacobsson G; Sellström H; Enander LK; Linné T; Svensson C
Ann Oncol; 1996 Aug; 7(6):593-600. PubMed ID: 8879373
[TBL] [Abstract][Full Text] [Related]
19. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of metastatic gastric cancer--x-ray follow-up].
Theobaldy S; Hofmann-Preiss K; Walter M
Radiologe; 1987 May; 27(5):235-6. PubMed ID: 3615855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
